BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12489117)

  • 1. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
    Snyder RD; Gillies PJ
    Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
    Snyder RD
    Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids.
    Snyder RD; Gillies PJ
    Food Chem Toxicol; 2003 Oct; 41(10):1291-8. PubMed ID: 12909261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.
    Cantero G; Campanella C; Mateos S; Cortés F
    Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay.
    Snyder RD; Arnone MR
    Mutat Res; 2002 Jun; 503(1-2):21-35. PubMed ID: 12052500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
    López-Lázaro M; Willmore E; Austin CA
    Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
    Markovits J; Linassier C; Fossé P; Couprie J; Pierre J; Jacquemin-Sablon A; Saucier JM; Le Pecq JB; Larsen AK
    Cancer Res; 1989 Sep; 49(18):5111-7. PubMed ID: 2548712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids.
    Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL
    Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells.
    Wang L; Roy SK; Eastmond DA
    Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DNA intercalation potential of pharmaceuticals and other chemicals by cell-based and three-dimensional computational approaches.
    Snyder RD; Ewing DE; Hendry LB
    Environ Mol Mutagen; 2004; 44(2):163-73. PubMed ID: 15278920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells lacking DNA topoisomerase II beta are resistant to genistein.
    López-Lazaro M; Willmore E; Austin CA
    J Nat Prod; 2007 May; 70(5):763-7. PubMed ID: 17411092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.
    Webb MR; Ebeler SE
    Biochem J; 2004 Dec; 384(Pt 3):527-41. PubMed ID: 15312049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin.
    Olaharski AJ; Mondrala ST; Eastmond DA
    Mutat Res; 2005 Apr; 582(1-2):79-86. PubMed ID: 15781213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187.
    Wang L; Eastmond DA
    Environ Mol Mutagen; 2002; 39(4):348-56. PubMed ID: 12112387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence.
    Kalfalah FM; Mielke C; Christensen MO; Baechler S; Marko D; Boege F
    Mol Nutr Food Res; 2011 May; 55 Suppl 1():S127-42. PubMed ID: 21520487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of atypical DNA intercalating agents in biological and in silico systems.
    Snyder RD
    Mutat Res; 2007 Oct; 623(1-2):72-82. PubMed ID: 17434187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrylamide catalytically inhibits topoisomerase II in V79 cells.
    Sciandrello G; Mauro M; Caradonna F; Catanzaro I; Saverini M; Barbata G
    Toxicol In Vitro; 2010 Apr; 24(3):830-4. PubMed ID: 20006698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
    Liang H; Wu X; Yalowich JC; Hasinoff BB
    Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.